SUPER
  1. Home
  2. Stocks
  3. ASC
  4. Peers

ASC · FOOD & PERSONAL CARE PRODUCTS

ASC against its peers Al Shaheer Corporation Limited

Al Shaheer Corporation Limited (ASC) is set against 10 peers in the FOOD & PERSONAL CARE PRODUCTS sector. By market value it ranks 11 of 11.

FOOD & PERSONAL CARE PRODUCTS peers on one table

CompanyLast close (Rs)Place in the 52-week rangeMarket valuePrice per rupee earned (12 months)
NESTLE7,011.358%Rs 318.0 bn18.01
COLG1,200.6859%Rs 291.5 bn15.35
UPFL26,457.9145%Rs 168.5 bn21.89
ISIL1,788.503%Rs 118.7 bn32.69
FCEPL140.3482%Rs 107.6 bn16.65
NATF337.9325%Rs 78.8 bn14.26
RMPL8,499.994%Rs 78.5 bn11.05
FFL14.7919%Rs 37.3 bn37.92
MUREB894.6329%Rs 24.7 bn6.18
BBFL37.9720%Rs 11.3 bn10.15
ASC (this company)7.794%Rs 2.9 bn—

Place in the range: 0% is the 52-week low and 100% the high, on closes adjusted for splits and bonus issues. The other companies are those in the same PSX sector that traded in the last 10 sessions. A sector median needs 1 or more companies. As of 13 Nov 2026.

Returns against the index and the sector

ASC return with dividends by window

1 month3 months6 monthsSince 1 January1 year3 years5 years-4.7%-38.1%-29.5%-37.9%-48.8%-5.4%-42.0%KSE-100
Return with dividends, not reinvested, over each window; the KSE-100 tick reinvests dividends too. Source: PSX closes, as of 13 Nov 2026.
WindowASC priceASC with dividendsKSE-100Sector median
1 month-4.65%-4.65%+7.53%-0.42%25 companies
3 months-38.08%-38.08%-1.24%-10.58%24 companies
6 months-29.50%-29.50%+7.41%-9.44%24 companies
Since 1 January-37.93%-37.93%+2.19%-17.09%22 companies
1 year-48.75%-48.75%+10.72%-17.31%22 companies
3 years-5.35%-5.35%+213.90%+73.61%20 companies
5 years-41.95%-41.95%+288.80%+29.42%20 companies

Price only: closes adjusted for bonus and rights issues, to the latest price. With dividends: adds cash dividends, not reinvested. The KSE-100 figure reinvests dividends. Source: PSX closes and payout notices.

More on ASC

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .